Great Company, Challenging Market - Senior Sales Professional Merck Employee Review

3.0
Oct 17, 2019
Recommend
CEO approval
Business Outlook

Pros

Merck is an excellent company with quality leadership.

Cons

However, this industry and company has changed dramatically. If you want to impact healthcare this is a great place to do it but understand there are significant challenges now that didn't exist just a few years ago: 1. R&D is harder and more expensive, 2. the public and most levels of government generally do not understand the complexity of healthcare at all and mostly think by simply passing a single piece of legislation all of healthcare's issues will be resolved (targeting pharmaceuticals), 3. access to providers is 4x harder than it was 10 years ago, and 4. the med-legal red tape just keeps getting deeper. Bottom line: this industry just went from "easy / moderate" to "stressful". This industry is about to shrink a little in headcount and become a little leaner and more efficient. The political climate may adversely impact the industry. Hopefully not.

Explore other reviews about Merck

5.0
Jul 12, 2026
Recommend
CEO approval
Business Outlook

Pros

Work Life Balance, Benefits, Remote Work

Cons

Easy to stagnate if not being proactive about building skills and networking

4.0
Jun 30, 2026
Recommend
CEO approval
Business Outlook

Pros

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Cons

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

See reviews by: Helpful|Rating|Date|All